Getting Approval

 

Quick links

Human Research Ethics

Research Governance Approval

Animal Ethics

Biosafety

MCRI Sponsorship

EMR Access

 

Before you can undertake your research there are certain institutional approvals you may need. This page covers all the different types of approval you may need and links you into more information on how to get these so you can start your research. 

Overview  

  Who needs it? When do I need to do this? Why do I need this?

Human Research Ethics Approval

  • All research with or about people, their data (even if de-identified) or tissue.
  • Must get approval before you commence the project
  • Needs to be reissued every time the project changes
  • Submissions via monthly deadlines for high risk research
  • Ensures that all research conducted in a way that is ethical and protects and respects participants.
  • Need evidence of approval for journal/thesis submission and funding applications.

Research Governance

Site specific authorisation
  • All human research (above) that is occurring at the Melbourne Children’s Campus.
  • If undertaking human research at other sites, you will need governance approval at those sites too.
  • Must get approval from each site’s Research Governance Office before you commence the project at that site
  • Needs to be reissued every time the project changes
  • Can apply at the same time as human ethics approval (need ethics approval from an appropriate HREC as well)
  • Ensures that the organisation has the capacity and ability to safely undertake the research.

Animal Ethics Approval

  • All researchers using live non-human vertebrates and cephalopods
  • Must get approval from the Animal Ethics Committee before you commence the project
  • Needs to be reissued every time the project changes
  • Ensure animals are safeguarded and that the use of animals for scientific purposes focuses on the 3R's principles – Replacement, Reduction and Refinement.
  • MCRI Animal Ethics Committee (AEC) approves and monitor all animal-based research at the Melbourne Children’s.

Biosafety Approval

  • Research using biohazards such as Genetically modified organisms (GMOs) or blood products.
  • Only applies for MCRI staff undertaking GMO work in RCH or MCRI space.
  • Must get the required approvals from the Institutional biosafety committee (IBC), and undertake the requisite training before you commence your project
  • Ensures that any risks to people or the environment related to storage, transport, use in certified facilities and disposal of GMOS are managed and contained.

Sponsorship Approval

  • All Investigator Initiated Clinical Trials which are being lead out of the MCRI
  • Must get approval before you commence the project
  • Can apply at the same time as human ethics approval
  • Ensures that the MCRI can monitor the risk that they take on as an institution
  • All trials which are being sponsored by the MCRI must receive a Certificate of Sponsorship before they can receive Ethics Approval

 

Staff and students conducting research with or about people, their data, or tissue, must apply for ethics approval.  

The definition of Human research is very broad and can include interviews/questionnaires with staff, accessing large clinical data sets from the EMR or archived human samples, or even just being observed by researchers.  

Before you can commence your research with or about human participants you must obtain human research ethics approval. This is irrespective of how risky your research is, but there are different approval processes depending on the risks associated with your research. 

The RCH Research Ethics & Governance office oversee ethics and governance approval of all research and can assist you with your application. Take some time to familiarise yourself with their website and all their excellent resources.  

At the Melbourne Children’s you submit ethics (to cover your own or multiple Australian hospital sites) and governance application at the same time for your human research proposal. 

1.  

Check out the ethics submission deadlinehow to submit information and handy templates 

2.  

Work out if your application is quality assurancelow risk researchmultisite researchsingle site research or had ethics approval elsewhere and is a governance only application 

3. 

Complete a draft ethics application form and any other documents (consent information statementsscripts, advertisements, questionnaires), and depending on type of application identified in part 2, any additional governance documents such as sponsorship committee approvalresearch agreements, indemnitiessupporting department declarations) based on your finalised protocol.   

4. 

Attend one of the ethics drop-in sessions or speak to the REG Office or your supervisor if you need any help or have any questions (get help and advice early!). This is particularly helpful is asking for a waiver of consentopt out consent and/or complex projects. 

5. 

Get your application peer reviewed and amend the projects based on any feedback you get.  

6. 

Finalise your ethics application, obtain relevant sign off, check you have included everything you need against the REG Checklist and submit (in time for the ethics deadline if high-risk research). 

7. 

Answer any questions or rebuttals that you get back from the REG office or committee until you obtain a letter indicating ethics and governance approval. Once you have both you can commence your research! 

8.

Once you have ethics and governance approval, please be sure to tell all parties involved in your research that you have approval. This may include your supporting departments like Clinical Trials Pharmacy or Medical Imaging, and the EMR Research team if your study is being built into EMR.

9. 

If your project changes at any stage you must submit an amendment to the application to the REG Office and get approval of the amendment before you implement the changes 

10. 

A condition of ethics and governance approval is that you submit annual reportsand notify them of any relevant safety notificationsbreaches or complaints. 

The MCRI Institutional Biosafety Committee (IBC) oversees compliance to The Gene Technology Act (2000) and the Gene Technology Regulations (2001) as well as assesses, approves, inspects and monitors research facilities to ensure that potential biological hazardous materials cause no harm to human, animal and environmental health.  

If you are working with biohazards such as Genetically modified organisms (GMOs) or blood products  you will need to approval from the IBC to ensure that any risks posed by your research are appropriately managed and containedIBC approval only covers the GMO undertaken at the MCRI or RCH. If you are using GMOS at other sites you will need to complete their institutional processes.  

What biosafety matters require approval or notification? 

The IBC requires approval or notification for: 

  • High risk cell lines  
  • Material of biological origin that may be or contain a hazard to humans such as toxins, allergens or prions 
  • Quarantine materials in any of the above categories 

Note: IBC responsibility does not extend to general laboratory risks and procedures involving the use of chemicals that are otherwise covered by  Health and Safety Policies or Procedures. 

1.  

Have a look at the approval process guideline and determine  

  • The classification of your GMO 
  • The type of GMO and if you need approval- if unsure contact the IBC secretariat on 8341 6361 

2.  

Complete an IBC application form. 

3. 

Contact the IBC on 8341 6361 for information on meeting deadlines and how to apply. 

4. 

Undertake the relevant training 

All projects involving the care and use of live animals or animal tissue must have the approval of the Animal Ethics Committee (AEC) prior to commencement. This includes: 

  • tissues for class experiments 
  • behavioural studies 
  • wildlife census data collection 
  • the use of fish 
  • animals or tissue obtained from third parties. 

1.  

Look at the MCRI AEC intranet site and familiarise yourself with the excellent SOPs and resources 

2.  

Check the AEC deadline date  

3. 

Complete and submit AE application form and complete and attach any relevant attachments (monitoring sheetsnew SOPS etc) 

4. 

Undertake compulsory training  

5. 

Commence your research! 

6. 

Submit any amendments to your project for approval before you implement the amendment 

7. 

Submit annual or final reports 

8. 

Report any adverse events or concerns 

 

Researchers that wish to access the RCH EMR for their ethically approved research must hold a position with RCH. Researchers from MCRI, VCGS, University of Melbourne or other external organisations will need to follow one of these two processes:

If you need help with this process please reach out to Kaya Gardiner.

Sponsorship

If your clinical trial does not have a commercial sponsor, and you would like the MCRI to act a Sponsor of a trial you need Sponsorship approval.

MCRI does not support individual members of staff to personally act as the sponsor of a clinical trial. Instead, the lead Investigator must apply to the MCRI Sponsorship Committee (SC) to request that MCRI take on the role of Sponsor.

The SC will assess the management, financing, safety, and overall integrity of their proposed trial using a risk based approach. Following review, the majority of Sponsorship responsibilities as dictated by ICH GCP are formally delegated to the lead Investigator, also known as the Sponsor-Investigator, a title that reflects the dual role of this position in the trial.

The MCRI sponsorship process applies to MCRI Investigator Initiated Trials and International trials which require a local Sponsor.

A MCRI led Clinical Trial will not be able to receive Ethics approval unless it has a Certificate of Sponsorship.
 

1.  

Look at the MCRI Launching Pad and familiarise yourself with the SOP and other resources.  

2.  

 Check the date of the next Sponsorship Committee Meeting 

3. 

Complete the Risk Matrix and application form 

4. 

Send a current trial budget, evidence of source of funding, and the completed Risk Matrix and application form to mctc@mcri.edu.au  

5. 

The application will be considered by the SC Chair. Trials of negligible risk will receive Sponsorship Approval immediately and skip to step 7 

6. 

If the trial is considered of higher than negligible risk, you will need to attend the next Sponsorship Committee Meeting to present and answer questions about your trial.  

7. 

Respond to any queries or amendment requests and resubmit your application. 

8. 

Submit your Certificate of Sponsorship to the Ethics Committee  

9. 

 Submit your updated Protocol, risk assessment, and trial budget at review intervals as determined by the SC at the time of approval.  

10. 

Update the risk assessment and notify the SC regarding any event that significantly alters the risk profile of the trial eg. Safety events, significant protocol deviations, failed recruitment targets, etc.  

 

Therapeutic Goods Administration - Drug/Device Trials only

A Clinical Trial Notification (CTN) is required if the study is using a drug or device that meets any of the following criteria:

  1. Not entered on the Australian Register of Therapeutic Goods, including any new formulation of an existing product or any new route of administration, or in the case of an existing medical device, new technology, new material or a new treatment modality; or
  2. Use of a product beyond the conditions of its marketing approval, including new indications extending the use of a medicine to a new population group and the extension of doses or duration of treatments outside the approved range. 

 

If you need to lodge a CTN, please complete the CTN Application Form and forward to the MCTC CTN Submission Officer, who will make the submission on your behalf.

 

For more information, please see CRDO’s SOP on Clinical Trial Registration.

Radiation Safety

If your study involved diagnostic or therapeutic ionising radiation, whether or not it is a part of routine clinical care, you must receive a safety report from a Medical Physicist prior to seeking Supporting Department sign off from medical imaging. Medical procedures that involve ionising radiation are:

  • Radiology: e.g.: CT scans, plain X-rays, EOS images, fluoroscopy, angiography
  • Cath lab: all procedures
  • Nuclear medicine: all scans, including Positron Emission Tomography (PET) and Gated blood pool scans
  • Endocrinology: DEXA scans
  • Radiotherapy (please contact the RSO before proceeding)

Please see here for more information on what you need to do if your research involves ionising radiation.